GlassScriptPhysician profile
Scott M Milstein
NPI 1922113034
$6,059.40
in general payments reported to CMS, 2019-2025
27 companies · $707 in 2025
The $707 reported for 2025 was more than what 80% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,596 · 2020: $1,318 · 2021: $435 · 2022: $975 · 2023: $27.58 · 2025: $707.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $734.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $734.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,114.48 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $919.71 | 2019-2022 | |
| Novo Nordisk INC | $683.60 | 2019-2025 | Ozempic, Rybelsus |
| Amgen INC. | $469.96 | 2019-2020 | |
| Lilly USA, LLC | $468.51 | 2019-2022 | |
| Amarin Pharma, INC. | $403.18 | 2019-2020 | |
| Glaxosmithkline, LLC. | $286.52 | 2019-2020 | |
| Astellas Pharma US INC | $223.57 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $218.36 | 2019-2022 | |
| Kowa Pharmaceuticals America, INC. | $215.47 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $188.28 | 2019-2020 | |
| Bolton Medical INC | $150.00 | 2025 | Treo Abdominal Stent-Graft System |
| Boston Scientific Corporation | $150.00 | 2025 | Enroute Transcarotid Neuroprotection System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $117.49 | 2019-2025 | Jardiance |
| Dexcom, INC. | $113.23 | 2022-2025 | Dexcom Stelo Glucose Biosensor, Dexcom G7 Gss (161) |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $93.64 | 2025 | Endurant Iis |
| Pfizer INC. | $52.11 | 2019-2022 | |
| Exact Sciences Corporation | $29.85 | 2025 | The Cologuard Plus Collection Kit |
| Teleflex LLC | $27.58 | 2023 | Urolift |
| Arbor Pharmaceuticals, INC. | $25.04 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.25 | 2022 | |
| Philips North America LLC | $17.12 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.24 | 2022 | |
| Abbvie INC. | $15.90 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.80 | 2020 | |
| Sanofi Pasteur INC. | $13.35 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $12.16 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Milstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.